Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(12/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(12/week)
News
United States
(633/week)
Manufacturing
(426/week)
Energy
(356/week)
Technology
(446/week)
Other Manufacturing
(359/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Mirati Therapeutics, Inc.
Dec 20, 2018
Mirati Therapeutics Added To NASDAQ Biotechnology Index
Dec 10, 2018
Mirati Therapeutics Announces The Appointment Of Maya Martinez-Davis To The Board Of Directors
Nov 29, 2018
Mirati Therapeutics Announces FDA Clearance Of Investigational New Drug (IND) Application To Initiate Phase 1/2 Trial Of KRAS G12C Inhibitor, MRTX849
Nov 20, 2018
Mirati Therapeutics To Present At The 30th Annual Piper Jaffray Healthcare Conference
Nov 09, 2018
Mirati Presents Preliminary Biomarker Data From Ongoing Phase 2 Clinical Trial Of Sitravatinib In Combination With Nivolumab At The SITC 33rd Annual Meeting
Nov 09, 2018
Mirati Presents Data From Ongoing Phase 2 Clinical Trial Of Mocetinostat In Combination With Durvalumab At The SITC 33rd Annual Meeting
Nov 08, 2018
Mirati Therapeutics Announces First Patient Dosed In Phase 1b Clinical Trial Of Sitravatinib In Combination With Anti-PD1 Antibody Tislelizumab In Patients With Advanced Solid Tumors
Nov 05, 2018
Mirati To Present New Data In Ongoing Phase 2 Clinical Trials At The SITC 33rd Annual Meeting
Oct 30, 2018
Mirati Therapeutics Announces Submission of IND Application for MRTX849, a KRAS G12C Inhibitor, to Treat Non-Small Cell Lung Cancer and Colorectal Cancer
Oct 22, 2018
Mirati Therapeutics Presents Updated Positive Clinical Data From Sitravatinib Immuno-Oncology Combination Trial At ESMO 2018 Congress And Announces FDA Guidance For Registration Trial
Oct 21, 2018
Mirati Therapeutics Announces Updated Data From Ongoing Clinical Trial Of Single Agent Sitravatinib At The 2018 ESMO Congress
Oct 15, 2018
Mirati Therapeutics To Provide Updated Sitravatinib Clinical Data At The European Society For Medical Oncology (ESMO) 2018 Congress And Conduct Investor Call
Aug 29, 2018
Mirati Therapeutics To Participate In Oncology Panels At The 2018 Citi Biotech Conference
Jul 24, 2018
Mirati Therapeutics To Present Updated Sitravatinib Clinical Data At The European Society For Medical Oncology (ESMO) 2018 Congress
Jun 25, 2018
Mirati Therapeutics Added to Russell 2000® Index
Jun 11, 2018
Mirati Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
Jun 07, 2018
Mirati Therapeutics Announces Pricing Of Public Offering Of Common Stock
Jun 06, 2018
Mirati Therapeutics Announces Proposed Public Offering of Common Stock
May 31, 2018
Mirati To Present New Data In Renal Cell Carcinoma From Ongoing Phase 1b Clinical Trial Of Single Agent Sitravatinib At The 2018 ASCO Annual Meeting
May 30, 2018
Mirati Therapeutics To Present At Jefferies 2018 Global Healthcare Conference
‹‹
Page 3
››
Latest News
May 11, 2024
KULR Technology Group Sets First Quarter 2024 Earnings Call for Wednesday, May 15, 2024 at 4:30 p.m. ET
May 11, 2024
Gilbane Crosses the Finish Line Delivering Massachusetts's First Dick's House of Sport
May 11, 2024
Intuit and REI champion climate action through Clearloop with new White Pine Solar Farm
May 11, 2024
Cleveland-Cliffs Applauds International Trade Commission’s Decision to Uphold Tariffs on Japanese Imports
May 11, 2024
Boeing Donates $100,000 to Support Tornado Recovery and Relief Efforts in Oklahoma
May 11, 2024
Asia-Pacific Wind-Assisted Propulsion Market Analysis and Forecast, 2023-2032 Featuring Prominent Players -...
May 11, 2024
Masco Corporation Declares Quarterly Dividend
May 10, 2024
Graham Packaging Company Inc. to Review 2024 First Quarter Results on May 14, 2024
View all News
Agenda
29
October
United Kingdom
Copthorne Tara Hotel, London, UK
International Dismounted Soldier, 29-30 October 2024, Copthorne Tara Hotel, London, UK
Navigating the Evolving Battlespace: Enhancing the Capabilities of the Dismounted Soldier The modern battlefield...
24
September
United Kingdom
Hilton London Syon Park, London, UK
Defence Transformation Conference, 24-26 September 2024, Hilton London Syon Park, London, UK
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
View All Events